Austin, Texas, United States
Business Analyst with experience leading cross-functional projects that require facilitating clear communication between teams with varying levels of technical and industry-specific knowledge. Comfortable reviewing and interpreting requirements, analyzing data, making decisions independently, and reporting results to stakeholders.
• Identified potential business risks for internal stakeholders, researched the associated healthcare regulations, performed analyses primarily using SQL and Excel, and provided Compliance and Legal teams with detailed but jargon-less explanations of the issues • Facilitated discussion in a weekly cross-team call including director-level members and leveraged Compliance/Legal guidance into actionable items for the business (30+ issues per week) • Led a cross-team process to manage and make approval decisions for 500+ monthly clinical study claims worth $1 million+ in net accounts receivable (A/R); reported monthly results to the director • Developed and maintained an Access database housing all Compliance data for the team • Administrated a SharePoint wiki aggregating all team process documents and resources
• Worked cross-functionally across 5 revenue ops teams to interpret the needs of the business, write business requirement documents, and develop the necessary solutions within the restrictions of the billing software, which included modification of proprietary scripting
• Conducted monthly deep dives to prevent negative impacts to A/R for clinics in 6 states expecting reimbursement from 50+ insurance payers • Reduced the team’s average outstanding support ticket volume by 70% over a 3-month period
• Reviewed and reported claims denials to metrics teams in order to increase revenue; worked directly with insurance payer representatives to resolve the underlying discrepancies
• Supported patient account representatives by completing billing adjustment projects and making cold calls to insurance payers; promoted in the first 3 months
• Conducted competitive analysis of Agilent, Intel, and others to devise new ways to promote the company to investors and sell-side analysts